A Phase II/III, Confirmatory, Randomized, Double-Blind, Parallel-Group Study to Assess the Safety and Immunogenicity of Subcutaneous BK-PIFA (H5N1 influenza vaccine) in Healthy Adult Japanese Volunteers

Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2006
This article has no abstract
Epistemonikos ID: afde8e7d0322035f1ff61aff986bfbc3e35d1585
First added on: Apr 16, 2025